Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds and their use for the treatment of alpha1-antitrypsin deficiency

Compounds and their use for the treatment of alpha1-antitrypsin deficiency

US Patent 11312689 · Granted Apr 26, 2022

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency2025
Compounds and their use for the treatment of ALPHA1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025
Compounds and their use for the treatment of alpha1-antitrypsin deficiency2025